Role of ERK signaling in pristimerin-induced apoptosis and autophagy: involvement of ROS-dependent mechanisms in Cutaneous T-cell lymphoma

This study investigates the role of ERK signaling in PS-induced apoptosis and autophagy. PS treatment activated MAP kinases in CTCL cells, with robust ERK activation contrasting with variable p38/JNK responses. Pharmacological ERK inhibition significantly reversed PS-mediated loss of viability, morphological and nuclear alterations, and apoptosis (PI/Annexin V). Mechanistically, ERK blockade suppressed PS-induced cleaved caspase-3, −8, −9, PARP, and γH2AX, confirming ERK drives proapoptotic cascades. PS also triggered autophagic flux, evidenced by increased LC3 and decreased Beclin1/p62, effects reversed by 3-methyladenine. ERK inhibition attenuated PS-induced MDC staining, indicating ERK-dependent autophagic cell death. Moreover, the ROS scavenger N-acetyl-L-cysteine inhibited both PS-induced ERK activation and apoptosis, positioning ROS upstream of ERK signaling. Altogether, these findings demonstrate that PS-mediates ERK-dependent proapoptotic and proautophagic signaling via ROS activity, suggesting ERK signaling as a key determinant of PS’s anticancer activity in CTCL.

Authors

Institutions

Publication Details

Journal
Leukemia & lymphoma/Leukemia and lymphoma
Published
2026-11-17
DOI
https://doi.org/10.1080/10428194.2026.2760718
Primary Topic
Cutaneous lymphoproliferative disorders research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Role of ERK signaling in pristimerin-induced apoptosis and autophagy: involvement of ROS-dependent mechanisms in Cutaneous T-cell lymphoma

Shahab Uddin M.S., Maha Al-Tamimi, Ummu Habeeba, Fareed Ahmad et al.
Leukemia & lymphoma/Leukemia and lymphoma
Cutaneous lymphoproliferative disorders research
article

Role of ERK signaling in pristimerin-induced apoptosis and autophagy: involvement of ROS-dependent mechanisms in Cutaneous T-cell lymphoma

Shahab Uddin M.S., Maha Al-Tamimi, Ummu Habeeba, Fareed Ahmad, Rasheeda Anver, Kirti Sathyananda Prabhu, Abdul Q. Khan
article en

Abstract

This study investigates the role of ERK signaling in PS-induced apoptosis and autophagy. PS treatment activated MAP kinases in CTCL cells, with robust ERK activation contrasting with variable p38/JNK responses. Pharmacological ERK inhibition significantly reversed PS-mediated loss of viability, morphological and nuclear alterations, and apoptosis (PI/Annexin V). Mechanistically, ERK blockade suppressed PS-induced cleaved caspase-3, −8, −9, PARP, and γH2AX, confirming ERK drives proapoptotic cascades. PS also triggered autophagic flux, evidenced by increased LC3 and decreased Beclin1/p62, effects reversed by 3-methyladenine. ERK inhibition attenuated PS-induced MDC staining, indicating ERK-dependent autophagic cell death. Moreover, the ROS scavenger N-acetyl-L-cysteine inhibited both PS-induced ERK activation and apoptosis, positioning ROS upstream of ERK signaling. Altogether, these findings demonstrate that PS-mediates ERK-dependent proapoptotic and proautophagic signaling via ROS activity, suggesting ERK signaling as a key determinant of PS’s anticancer activity in CTCL.

Leukemia & lymphoma/Leukemia and lymphoma
Hamad Medical Corporation (QA)
Cutaneous lymphoproliferative disorders research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon